Top

Annals of Behavioral Medicine

Published in:

01-06-2008 | Original Article

Exploring Refinements in Targeted Behavioral Medicine Intervention to Advance Public Health

Authors: Abby C. King, Ph.D., David F. Ahn, Ph.D., Audie A. Atienza, Ph.D., Helena C. Kraemer, Ph.D.

Published in: Annals of Behavioral Medicine | Issue 3/2008

Abstract

Background

Similar to other fields, a targeted behavioral medicine perspective can aid decision-making related to participant–intervention matching.

Purpose

To present one potentially useful definition of intervention targeting activity; describe potential targeting domains of particular relevance to behavioral medicine; discuss different statistical approaches to aid the targeted intervention development process; and discuss the challenges and opportunities accompanying the incorporation of targeted intervention development methods into behavioral randomized clinical trial (RCT) research.

Methods

Drawing from recent conceptual work by the MacArthur group and other scientists in the field, methods and approaches to undertaking moderator analysis are discussed.

Results

Examples of moderator analyses are provided which reflect the different statistical methods and variable domains that may serve as moderators of intervention success.

Conclusions

The recommended exploratory work can help to make the most efficient use of RCTs to identify the best paths for subsequent RCT development in a resource-constrained era.

Office of Behavioral and Social Sciences Research. Healthier Lives through Behavioral and Social Sciences Research. Bethesda, MD: OBSSR, National Institutes of Health; 2006.

Ockene JK, Emmons KM, Mermelstein RJ, et al. Relapse and maintenance issues for smoking cessation. Health Psychol. 2000; 19: 17–31.PubMedCrossRef

Haskell WL, Alderman EL, Fair JM, et al. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease: The Stanford Coronary Risk Intervention Project (SCRIP). Circulation. 1994; 89: 975–990.PubMed

Lorig KR, Mazonson PD, Holman HR. Evidence suggesting that health education for self-management in patients with chronic arthritis has sustained health benefits while reducing health costs. Arthritis Rheum. 1993; 36: 439–446.PubMedCrossRef

Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New Engl J Med. 2002; 346: 393–403.CrossRef

Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001; 344: 1343–1350.PubMedCrossRef

Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997; 20: 537–544.PubMedCrossRef

Durantini MR, Albarracin D, Mitchell AL, Earl AN, Gillette JC. Conceptualizing the influence of social agents of behavior change: A meta-analysis of the effectiveness of HIV-prevention interventionists for different groups. Psychol Bull. 2006; 132: 212–248.PubMedCrossRef

Christensen AJ. Patient-by-treatment context interaction in chronic disease: A conceptual framework for the study of patient adherence. Psychosom Med. 2000; 62: 435–443.PubMed

10.

Evans WE, Relling MV. Moving towards individualized medicine with pharmacogenomics. Nature. 2004; 429: 464–468.PubMedCrossRef

11.

Owens EB, Hinshaw SP, Kraemer HC, Arnold LE, Abikoff HB, Cantwell DP, et al. Which treatment for whom for ADHD? Moderators of treatment response in the MTA. J Consult Clin Psychol. 2003; 71: 540–552.PubMedCrossRef

12.

Orleans TC, Gruman J, Ulmer C, Emont SL, Hollendonner JK. Rating our progress in population health promotion: Report card on six behaviors. Am J Health Promot. 1999; 14: 75–82.PubMed

13.

Campbell MK, Tessar O, DeVellis B, et al. Effects of a tailored health promotion program for female blue-collar workers: Health works for women. Prev Med. 2002; 34: 313–323.PubMedCrossRef

14.

King AC, Bauman A, Calfas K. Innovative approaches to understanding and influencing physical activity. Am J Prev Med. 2002; 232 Suppl: 56–63.

15.

Mattson ME, Allen JP. Research on matching alcoholic patients to treatments: Findings, issues, and implications. J Addict Dis. 1991; 11: 33–49.PubMedCrossRef

16.

Kent D, Hayward R. When averages hide individual differences in clinical trials. Am Sci. 2007; 95: 60–68.

17.

Kraemer HC, Wilson GT, Fairburn CG, Agras WS. Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry. 2002; 59: 887–883.CrossRef

18.

Zerhouni EA. NIH in the postdoubling era: Realities and strategies for the future. In: NIMH Council Meeting; September; Bethesda, MD; 2006.

19.

Murphy GM Jr., Hollander SB, Rodrigues C, Krema C, Schatzberg AF. Effects of the serotonic transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression. Arch Gen Psychiatry. 2004; 61: 1163–1169.PubMedCrossRef

20.

Rothwell PM. Treating individuals 1: External validity of randomised controlled trials: “To whom do the results of this trial apply?”. The Lancet. 2005; 365: 82–93.CrossRef

21.

Kraemer HC, Frank E, Kupfer DJ. Moderators of treatment outcomes: Clinical, research, and policy importance. JAMA. 2006; 296: 1286–1289.PubMedCrossRef

22.

Napolitano MA, Marcus BH. Targeting and tailoring physical activity information using print and information technologies. Exerc Sport Sci Rev. 2002; 30: 122–128.PubMedCrossRef

23.

Moyer A, Finney JW, Elworth JT, Kraemer HC. Can methodological features account for patient–treatment matching findings in the alcohol field? J Stud Alcohol. 2001; 62: 62–73.PubMed

24.

Skinner HA. Different strokes for different folks: Differential treatment for alcohol abuse. In: Meyer RE, Babor TF, Glueck BC, Jaffe JH, O’Brien JE, Stabenau JR, eds. Evaluation of the Alcoholic: Implications for Research, Theory, and Treatment. Washington, DC: Government Printing Office; 1981: 349–367.

25.

Marcus BH, Bock BC, Pinto BM, Forsyth LH, Roberts MB, Traficante RM. Efficacy of an individualized, motivationally-tailored physical activity intervention. Ann Behav Med. 1998; 20: 174–180.PubMedCrossRef

26.

Strecher VJ, Marcus A, Bishop K, et al. A randomized controlled trial of multiple tailored messages for smoking cessation among callers to the Cancer Information Service. J Health Commun. 2005; 10: 105–118.PubMedCrossRef

27.

Killen JD, Fortmann SP, Kraemer HC, Varady A, Newman B. Who will relapse? Symptoms of nicotine dependence predict long-term relapse after smoking cessation. J Consult Clin Psychol. 1992; 60: 797–801.PubMedCrossRef

28.

Winkleby MA, Flora JA, Kraemer HC. A community-based heart disease intervention: Predictors of change. Am J Publ Health. 1994; 84: 767–772.

29.

King AC, Satariano W, Marti J, Zhu W. Multi-level modeling of walking behavior: Advances in understanding the interactions of people, place, and time. Med Sci Sports Exerc, 2008;in press.

30.

Wilcox S, Dowda M, Griffin SF, et al. Results of the first year of Active for Life: Translation of two evidence-based physical activity programs for older adults into community settings. Am J Publ Health. 2006; 96: 1201–1209.CrossRef

31.

King AC, Castro C, Wilcox S. From science to practice and back again: Predictors of successful physical activity participation in a telephone-based dissemination research program. Int J Behav Nutr Phys Act. 2008;5(abstract).

32.

Castro FG, Barrera M Jr, Martinez CR Jr. The cultural adaptation of prevention interventions: Resolving tensions between fidelity and fit. Prev Sci. 2004; 5: 41–45.PubMedCrossRef

33.

Munoz RF, Mendelson T. Toward evidence-base interventions for diverse populations: The San Francisco General Hospital Prevention and Treatment Manuals. J Consult Clin Psychol. 2005; 73: 790–799.PubMedCrossRef

34.

Behrens JT. Principles and procedures of exploratory data analysis. Psychol Methods. 1997; 2: 131–160.CrossRef

35.

Greenhouse JB, Greenhouse JBW. Exploratory statistical methods, with applications to psychiatric research. Psychoneuroendocrinology. 1992; 17: 423–441.PubMedCrossRef

36.

Tukey J. Exploratory Data Analysis. Reading, MA: Addison-Wesley; 1977.

37.

Wilkinson L, The Task Force on Statistical Inference of the APA Board of Scientific Affairs. Statistical methods in psychology journals: Guidelines and explanations. Am Psychol. 1999; 54: 594–604.CrossRef

38.

Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM. Statistics in medicine—Reporting of subgroup analyses in clinical trials. N Engl J Med. 2007; 357: 2189–2194.PubMedCrossRef

39.

King AC, Kiernan M, Oman RF, Kraemer HC, Hull M, Ahn D. Can we identify who will adhere to long-term physical activity? Application of signal detection methodology as a potential aid to clinical decision-making. Health Psychol. 1997; 16: 380–389.PubMedCrossRef

40.

Schneiderman N, Saab PG, Catellier DJ, et al. Psychosocial treatment within sex by ethnicity subgroups in the Enhancing Recovery in Coronary Heart Disease clinical trial. Psychosom Med. 2004; 66: 475–483.PubMedCrossRef

41.

King AC, Stokols D, Talen E, Brassington GS, Killingsworth R. Theoretical approaches to the promotion of physical activity: Forging a transdisciplinary paradigm. Am J Prev Med. 2002; 232S: 15–25.PubMedCrossRef

42.

Kraemer HC, Stice E, Kazdin A, Offord D, Kupfer D. How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. Am J Psychiatr. 2001; 158: 848–856.PubMed

43.

King AC, Marcus BH, Dunn AL, et al. Identifying subgroups who succeed or fail with three physical activity interventions: The Activity Counseling Trial. Health Psychol. 2006; 25: 336–347.PubMedCrossRef

44.

Kiernan M, King AC, Stefanick M, Kraemer HC. Characteristics of successful and unsuccessful dieters: An application of signal detection methodology. Ann Behav Med. 1998; 20: 1–6.PubMedCrossRef

45.

Berry DA, Cirrincione C, Henderson IC, et al. Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer. JAMA. 2006; 295: 1658–1667.PubMedCrossRef

46.

Killen JD, Fortmann SP, Davis L, Strausberg L, Varady A. Do heavy smokers benefit from higher dose nicotine patch therapy? Exp Clin Psychopharmacol. 1999; 7: 226–233.PubMedCrossRef

47.

Pittas AG, Das SK, Hajduk CL, et al. A low-glycemic load diet facilitates greater weight loss in overweight adults with high insulin secretion but not in overweight adults with low insulin secretion in the CALERIE Trial. Diabetes Care. 2005; 28: 2939–2941.PubMedCrossRef

48.

Ebbeling CB, Leidig MM, Feldman HA, Lovesky MM, Ludwig DS. Effects of a low-glycemic load vs low-fat diet in obese young adults: A randomized trial. JAMA. 2007; 297: 2092–2102.PubMedCrossRef

49.

Cornier MA, Donahoo WT, Pereira R, et al. Insulin sensitivity determines the effectiveness of dietary macronutrient composition on weight loss in obese women. Obes Res. 2005; 13: 703–709.PubMedCrossRef

50.

Sallis JF, Owen N. In: Glanz K, Rimer BK, Lewis FM, eds. Health Behavior and Health Education: Theory, Research, and Practice. Ecological models of health behavior. 3rd ed. San Francisco: Jossey-Bass; 2002: 462–484.

51.

Murphy SA. An experimental design for the development of adaptive treatment strategies. Stat Med. 2005; 24: 1455–1481.PubMedCrossRef

52.

Collins LM, Murphy SA, Nair VN, Strecher VJ. A strategy for optimizing and evaluating behavioral interventions. Ann Behav Med. 2005; 30: 65–73.PubMedCrossRef

53.

Insel TR. Beyond efficacy: The STAR*D trial. Am J Psychiatry. 2006; 163: 5–7.PubMedCrossRef

54.

Rush AJ, Trivedi M, Fava M. Depression, IV: STAR*D treatment trial for depression. Am J Psychiatry. 2003; 160: 237–245.PubMedCrossRef

55.

Trivedi MH, Fava M, Wisniewski SR, et al. Medication augmentation after the failure of SSRIs for depression. N Engl J Med. 2006; 354: 1243–1252.PubMedCrossRef

56.

Killen JD, Fortmann SP, Kraemer HC, Varady AN, Davis L, Newman B. Interactive effects of depression symptoms, nicotine dependence, and weight change on late smoking relapse. J Consult Clin Psychol. 1996; 64: 1060–1067.PubMedCrossRef

57.

Biddle SJH, Nigg CR. Theories of exercise behavior. Int J Sport Psychol. 2000; 31: 290–304.

58.

King AC, Friedman R, Marcus B, et al. Harnessing motivational forces in the promotion of physical activity: The Community Health Advice by Telephone (CHAT) Project. Health Educ Res. 2002; 17: 627–636.PubMedCrossRef

59.

Williams GG, Gagne M, Ryan RM, Deci EL. Facilitating autonomous motivation for smoking cessation. Health Psychol. 2002; 21: 40–50.PubMedCrossRef

60.

Efron B. The efficiency of logistic regression compared to normal discriminant. J Am Stat Assoc. 1975; 70: 892–898.CrossRef

61.

Kiernan M, Kraemer HC, Winkleby MA, King AC, Taylor CB. Do logistic regression and signal detection identify different subgroups at risk? Implications for the design of tailored interventions. Psychol Methods. 2001; 6: 35–48.PubMedCrossRef

62.

Kraemer HC. Evaluating Medical Tests: Objective and Quantitative Guidelines. Newbury Park, CA: Sage; 1992.

63.

King AC, Toobert D, Ahn D, et al. Perceived environments as physical activity correlates and moderators of interventions in five studies. Am J Health Promot. 2006; 21: 24–35.PubMed

64.

Kraemer HC. Toward non-parametric and clinically meaningful moderators and mediators. Stat Med. 2007; 27(10): 1679–1692.

65.

Cook RJ, Sackett DL. The number needed to treat: A clinically useful measure of treatment effect. Br Med J. 1995; 310: 452–454.

66.

Grissom RJ, Kim JJ. Effect Sizes for Research. Mahwah, NJ: Erlbaum; 2005.

67.

King AC, Haskell WL, Taylor CB, Kraemer HC, DeBusk RF. Group- versus home-based exercise training in healthy older men and women: A community-based clinical trial. JAMA. 1991; 266: 1535–1542.PubMedCrossRef

68.

Gaudard M, Ramsey P, Stephens M. Interactive data mining and design of experiments: The JMP partition and custom design platforms. In: JMP version 5.1.2 (SAS). Cary, NC: SAS; 2006.

69.

Lemon SC, Roy J, Clark MA, Friedmann PD, Rakowski W. Classification and regression tree analysis in public health: Methodological review and comparison with logistic regression. Ann Behav Med. 2003; 26: 172–181.PubMedCrossRef

70.

Kraemer HC. Assessment of 2 X 2 association: Generalization of signal detection methods. Am Stat. 1988; 42: 37–49.CrossRef

71.

Glasgow RE, Lichtenstein E, Marcus AC. Why don’t we see more translation of health promotion research to practice? Rethinking the efficacy-to-effectiveness transition. Am J Publ Health. 2003; 93: 1261–1267.

72.

Davidson KW, Goldstein M, Kaplan RM, et al. Evidence-based behavioral medicine: What is it and how do we achieve it? Ann Behav Med. 2003; 26: 161–171.PubMedCrossRef

73.

Rosen L, Manor O, Engelhard D, Zucker D. In defense of the randomized controlled trial for health promotion research. Am J Publ Health. 2006; 96: 1181–1186.CrossRef

74.

Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: The RE-AIM framework. Am J Publ Health. 1999; 89: 1322–1327.CrossRef

75.

Atienza AA, Yaroch AL, Masse LC, Moser RP, Hesse BW, King AC. Identifying sedentary subgroups: The National Cancer Institute’s Health Information National Trends Survey. Am J Prev Med. 2006; 31: 383–390.PubMedCrossRef

76.

Pickering TG, Shimbo D, Haas D. Ambulatory blood pressure monitoring. New Engl J Med. 2006; 354: 2368–2374.PubMedCrossRef

77.

Pence C, McErlane K. Anticoagulation self-monitoring. Am J Nurs. 2005; 105: 62–65.PubMed

78.

Harris ND, Baykouchev SB, Marques JL, et al. A portable system for monitoring physiological responses to hypoglycaemia. J Med Eng Technol. 1996; 20: 196–202.PubMedCrossRef

79.

Patrick K, Intille SS, Zabinsky MF. An ecological framework for cancer communication: Implications for research. J Med Internet Res. 2005; 7: 1–7.CrossRef

Title: Exploring Refinements in Targeted Behavioral Medicine Intervention to Advance Public Health
Authors: Abby C. King, Ph.D.
David F. Ahn, Ph.D.
Audie A. Atienza, Ph.D.
Helena C. Kraemer, Ph.D.
Publication date: 01-06-2008
Publisher: Springer-Verlag
Published in: Annals of Behavioral Medicine / Issue 3/2008
Print ISSN: 0883-6612
Electronic ISSN: 1532-4796
DOI: https://doi.org/10.1007/s12160-008-9032-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Exploring Refinements in Targeted Behavioral Medicine Intervention to Advance Public Health

Abstract

Background

Purpose

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2008

Relation Between Central Adiposity and Cognitive Function in the Maine–Syracuse Study: Attenuation by Physical Activity

Clinical Implications of Numeracy: Theory and Practice

Exercise Preferences and Environmental Contexts: A Response to King and Wilcox

Lifetime Characteristics of Participants and Non-participants in a Smoking Cessation Trial: Implications for External Validity and Public Health Impact

Promoting Fruit and Vegetable Intake through Messages Tailored to Individual Differences in Regulatory Focus

Effects of Mindfulness-Based Stress Reduction Intervention on Psychological Well-being and Quality of Life: Is Increased Mindfulness Indeed the Mechanism?